Search research articles
Contact Us
Filters
Showing results (91-100 of 129) with videos related to
Page
of 13
Sort By:
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|
January 1, 1992
[Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies]
P Carde, C Chastang, E Goncalves, et al.
Bone Marrow Transplantation
|
April 21, 2001
Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy
J M Vantelon, J N Munck, J H Bourhis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-Curie
E M Noordijk, P Carde, A M Mandard, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 6, 2003
Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients
R M'kacher, T Girinsky, S Koscielny, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 1990
Immunoscintigraphy of Hodgkin's disease: in vivo use of radiolabelled monoclonal antibodies derived from Hodgkin cell lines
P Carde, L Da Costa, L Manil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2001
Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases
P Carde, R Timmerman, M P Mehta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1994
A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial
R Somers, P Carde, M Henry-Amar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group
P Carde, A Hagenbeek, M Hayat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas
D Decaudin, J Bosq, G Tertian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1990
Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group
M Henry-Amar, M Hayat, J H Meerwaldt, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 129) with videos related to
Sort By:
Page
of 13
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|
January 1, 1992
[Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies]
P Carde, C Chastang, E Goncalves, et al.
Bone Marrow Transplantation
|
April 21, 2001
Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy
J M Vantelon, J N Munck, J H Bourhis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-Curie
E M Noordijk, P Carde, A M Mandard, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 6, 2003
Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients
R M'kacher, T Girinsky, S Koscielny, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 1990
Immunoscintigraphy of Hodgkin's disease: in vivo use of radiolabelled monoclonal antibodies derived from Hodgkin cell lines
P Carde, L Da Costa, L Manil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2001
Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases
P Carde, R Timmerman, M P Mehta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1994
A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial
R Somers, P Carde, M Henry-Amar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group
P Carde, A Hagenbeek, M Hayat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas
D Decaudin, J Bosq, G Tertian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1990
Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group
M Henry-Amar, M Hayat, J H Meerwaldt, et al.
Page
of 13